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Abstract
Clinical and experimental evidence document that inflammation and increased peripheral cytokine levels are associated with
depression-like symptoms and neuropsychological disturbances in humans. However, it remains unclear whether and to what
extent cognitive functions like memory and attention are affected by and related to the dose of the inflammatory stimulus. Thus, in
a cross-over, double-blind, experimental approach, healthy male volunteers were administered with either placebo or bacterial
lipopolysaccharide (LPS) at doses of 0.4 (n=18) or 0.8 ng/kg of body weight (n=16). Pro- and anti-inflammatory cytokines,
norephinephrine and cortisol concentrations were analyzed before and 1, 1.75, 3, 4, 6, and 24 h after injection. In addition, changes
in mood and anxiety levels were determined together with working memory (n-back task) and long term memory performance
(recall of emotional and neutral pictures of the International Affective Picture System). Endotoxin administration caused a profound
transient physiological response with dose-related elevations in body temperature and heart rate, increases in plasma interleukin
(IL)-6, IL-10, tumor necrosis factor (TNF)-a and IL-1 receptor antagonist (IL-1ra), salivary and plasma cortisol, and plasma
norepinephrine. These changes were accompanied by dose-related decreased mood and increased anxiety levels. LPS
administration did not affect accuracy in working memory performance but improved reaction time in the high-dose LPS condition
compared to the control conditon. In contrast, long-term memory performance was impaired selectively for emotional stimuli after
administration of the lower but not of the higher dose of LPS. These data suggest the existence of at least two counter-acting
mechanisms, one promoting and one inhibiting cognitive performance during acute systemic inflammation.
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Introduction
The release of pro-inflammatory cytokines during infection and
inflammation can affect behavior, mood, and functioning of the
central nervous system (CNS) [1,2,3]. Behavioral changes induced
by immune activation include symptoms such as psychomotor
slowing, social withdrawal, anhedonia, depressed mood, and
disturbed sleep architecture, collectively termed ‘‘sickness behavior’’
[4,5,6]. In addition, there is growing experimental and clinical
evidence implicating systemic inflammation to be involved in the
pathophysiology of neuropsychiatric diseases such as depression
and schizophrenia as well as age-related cognitive decline
[7,8,9,10,11,12,13,14]. Animal and human studies suggest that
pro-inflammatory cytokines such as interleukin (IL)-1, IL-6, and
tumor necrosis factor (TNF)-a play a pivotal role in mediating
sickness-related behavior and cognitive impairments by communi-
cating peripheral inflammation to the brain [1,3,15,16,17]. Studies
in experimental animals demonstrated that systemic immune
activation by viral, bacterial, or parasitic infections result in
impaired memory functioning [18,19,20,21,22,23]. Experimental
approaches in humans, employing lipopolysaccharide (LPS)-
induced immune activation to investigate the effects of a peripheral
inflammatory response on learning and memory reported either
increased [24], no [25,26,27] or decreased [28] cognitive
performance after LPS administration. Reasons for these discrep-
ancy might be the different quality and concentrations of LPS
administered together with distinct time intervals of testing memory
performance and the different memory processes analyzed [25].
Therefore, the current study analyzed memory performance
before and after administration of two different dosages of LPS in
healthy humans in a double blinded, cross-over, placebo-controlled
design (Fig. 1). Subjects either received an injection of 0.4 ng/kg
(n=18) or 0.8 ng/kg (n=16) LPS or placebo, respectively, and were
tested for working memory and long-term memory performance.
Furthermore, self reported mood, attention, and anxiety was
assessed. Blood samples were drawn before and 1, 1.75, 3, 4, 6,
and 24 hours after LPS or placebo administration and analyzed for
plasma levels of pro- and anti-inflammatory cytokines as well as
cortisol and norepinephrine concentrations.
Materials and Methods
Ethics Statement
The study was approved by the local ethics committee of the
University of Duisburg-Essen and follows the rules stated in the
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28330Declaration of Helsinki. Study participants were informed about
the study design, and were only enrolled in the experiment after
written informed consent had been obtained.
Subjects
Thirty-four male subjects participated in the study. They were
randomly allocated to one of the two experimental groups (see
below). All subjects underwent an extensive physical and
psychiatric screening. The physical examination included a
complete blood cell count, liver enzymes, renal parameters,
electrolytes, coagulation factors, and C-reactive protein (CRP). An
interview was conducted to exclude the presence or history of any
physical or psychiatric disorder. The groups did not differ in age,
years of education or body weight, nor in any of the physical or
psychological screening parameters, and there was no detectable
influence of these parameters on any of the outcome measures.
Subjects and investigators where blinded with respect to the study
condition.
Experimental design
In this placebo-controlled, double-blind, crossover study,
participants were randomly allocated to two different groups: the
high-dose group (n=16; mean age: 25.363.3 years; range: 19–29
years; mean body mass index (BMI): 23.062.5; range: 19.4–27.2)
received a dose of 0.8 ng LPS per kg of body weight on one
occasion and placebo (0.9% saline) on another occasion in
balanced order; in the low-dose group (n=18; mean age:
26.463.2 years; range: 20–33 years; BMI: 24.662.6; range:
20.3–30.5), subjects received 0.4 ng LPS per kg and placebo on
two different occasions. Between the two experimental conditions
was a rest period of 10 to 14 days. The experiments were
conducted in a medically equipped room and were supervised by
emergency physicians of the Department of Trauma Surgery. An
intravenous cannula was inserted into the antecubital forearm vein
for intermittent blood sampling and drug injection. Saline and
LPS injections were always performed around noon. The
endotoxin (Escherichia coli, Lot G3E069, United States Pharmaco-
peia, Rockville, Maryland, USA) had been prepared for use in
humans. Briefly, the lyophilized LPS was dissolved in sterile water,
filtered through a 0.2-mm membrane, and subjected to a microbial
safety testing routine approved by the German Federal Agency for
Sera and Vaccines (Paul-Ehrlich Institute, Langen, Germany).
The LPS solution was stored in endotoxin-free borosilicate tubes at
220uC until use. During the experimental sessions, the subjects
completed questionnaires concerning their mental state and
performed several neuropsychological tests (see below). Blood
and saliva samples were drawn at baseline and 1, 1.75, 3, 4, 6, and
24 h post-injection. Plasma for the measurement of cytokine,
cortisol, and norepinephrine levels was separated by centrifugation
and stored at 280uC until analysis. Temperature, heart rate, and
blood pressure were analyzed immediately prior to the blood
collections using an aural thermometer and a blood pressure cuff.
At the end of each experimental day, subjects underwent a
physical examination before being discharged from the clinical
research unit and returned for thorough follow-up examinations
24 h and 1 week after the experimental session.
Cytokine and hormone determinations
Plasma cytokine concentrations were quantified using multi-
plexed bead-based assays (Bio-Plex Cytokine Assays, Bio-Rad
Laboratories GmbH, Munich, Germany). Samples were prepared
according to the manufacturer’s instructions and were analyzed on
a triple-laser FACSCanto II flow cytometer using FACSDiva
software (BD Immunocytometry Systems, Heidelberg, Germany).
Absolute cytokine levels were calculated based on the mean
fluorescence intensity of cytokine standard dilutions with a 4
Parameter Logistics (4PL) curve model using GraphPad Prism 5
(GraphPad Software Inc., La Jolla, CA, USA). The detection limit
of the assays was 60 pg/ml for IL-1ra, 0.2 pg/ml for IL-6, 0.4 pg/
ml for IL-10, and 3 pg/ml for TNF-a. Plasma levels of cortisol and
norepinephrine and salivary levels of cortisol were determined
using enzyme-linked immunosorbent assays (ELISA; Labor
Diagnostika Nord, Nordhorn, Germany [norepinephrine] and
IBL International, Hamburg, Germany [cortisol]) according to the
test protocol of the manufacturer, and were analyzed on a Fluostar
OPTIMA Microplate Reader (BMG Labtech, Offenbach, Ger-
many). The detection limits were 50 pg/ml (norepinephrine) and
0.83 nmol/l (cortisol), respectively.
Mood and Anxiety Questionnaires
Subjects had to complete two standardized self-report question-
naires immediately before as well as 3 and 6 h after LPS or saline
Figure 1. Experimental design. Volunteers arrived 1 h prior to the experiment. Thirty minutes before the injection, an intravenous cannula was
inserted into the antecubital forearm vein for intermittent blood sampling and drug injection. Before and 1, 1.75, 3, 4, and 6 h after the injection
blood samples (B) were collected and vital parameters were assessed. Before as well as 3 and 6 h after the injection the subjects completed mood
and anxiety questionnaires (M). After the 1.75 h blood collection the n-back task was performed, and before the 3 h collection the acquisition for the
long-term memory test took place. When showing no signs of inflammation or any other kind of illness, subjects were discharged and returned on
the following day for follow-up examination and completing the long-term memory task. The whole procedure was repeated on another study day
with a 10–14 days delay. Every participant received the higher or lower dose of LPS during one and saline during the other test session in a balanced,
randomized manner.
doi:10.1371/journal.pone.0028330.g001
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dimensionaler Befindlichkeitsfragebogen, MDBF), which is a well-
established and -validated scale in German language. The MDBF
provides sub-scales for positive vs. negative mood, alertness vs.
fatigue and calmness vs. uneasiness [29,30]. 2. The State Trait
Anxiety Inventory (STAI, state version), a widely used scale to
quantify anxiety in health research [31,32]. The STAI consists of
twenty items with four answer choices each.
Memory tests
Between the blood withdrawals at 1.75 and 3 h, the n-back task
(2-back version) for working memory performance and the first part
of the long-term memory task took place. The n-back task is a
common and well-established continuous performance test for
measurements of working memory performance [33,34]. After a
training block, which was not assessed, a sequence of 155 letters,
divided into 5 blocks of 31 letters was presented on a screen. Within
a block each letter was presented for 1 second directly followed by
the next. After each block there was a break of 30 seconds. The
subjects were told to press a button whenever the current letter
shown was the same as the last but one (Fig. S2). Overall the test
included 25 of those adequate stimuli, which were distributed
randomlyoverthe entire sequence.The software(n-Back fmri v0.93
by Frank Schulte used on a Sony Vaio laptop computer) allows
assessing the number of false and correct reactions as well as the
reaction time that is needed to press the button after the appearance
of an adequate stimulus. To evaluate the subjects’ working memory
performance, accuracy was calculated by subtracting the number of
reactions to inadequate stimuli (false alarms) from the number of
correct reactions to the adequate stimuli.
In order to analyze long-term memory performance, subjects
were presented a randomized sequence of 72 pictures from the
International Affective Picture System (IAPS, see Fig. S1 for
examples). The images were presented back to back for three
seconds, respectively on a laptop computer screen. Whereas 50%
of pictures had neutral contents and were reported to elicit
medium levels of valence and low levels of arousal, 50% of pictures
consisted of highly emotional pictures known to elicit high arousal
and low valence values [35]. 24 h after the administration of LPS
or placebo, respectively, participants were presented a second
sequence of 40 pictures containing 20 of those they were presented
the day before and 20 new ones of similar content, again with 50%
of emotional and 50% of neutral content, respectively. Subjects
were asked to indicate every recognized picture. For evaluation of
memory performance accuracy was calculated by subtracting the
number of new pictures remembered by mistake (false alarms)
from the number of correctly recognized stimuli (correct hits) for
every subject. Since all subjects participated in two experimental
days (receiving LPS or saline as a control condition) we employed
two counter-balanced, randomly applied sets of IAPS pictures.
Statistics
Statistical analyses were performed using SPSS 17 (SPSS Inc.,
Chicago, IL) and GraphPad Prism 5 (GraphPad Software, Inc.,
San Diego, CA). For the analyses of temperature, heart rate,
cytokines, hormones, and mood parameters differences between
experimental and control condition were analyzed using repeated
measures analysis of variance (ANOVA) with ‘treatment’ as
between-subjects factor (LPS/placebo) and ‘time’ as repeated
measures within-subject factor. In case of a significant time6
treatment interaction, Bonferroni post hoc tests were computed to
assess mean differences between the control and endotoxin
condition for specific time points. Absolute changes in body
temperature, heart rate, cytokine concentrations, hormone
concentrations, and mood following endotoxin administration
were calculated by subtracting the control values of each
individual from the corresponding values of the experimental
condition. To compare those changes between the low-dose and the
high-dose groups, repeated measures ANOVA followed by Bonfer-
roni post hoc test was used. Differences in the n-back task for
working memory were calculated using ANOVA with group as
between subjects and treatment as within subject factor followed
by Bonferroni post hoc tests. Differences in the long term memory
task were computed by ANOVA with group as between subject
factor and treatment and stimulus-quality (emotionality) as
between-subject factors, followed by Bonferroni corrected paired
and unpaired t-tests. In all statistical analyses p,0.05 was
considered significant.
Most of the data reported here were normally distributed
(Kolmogorov-Smirnov and the D’Agostino and Pearson omnibus
normality test). We observed non-normal distributions for TNF-a
levels (4–24 h, both groups), IL-6 levels (4 h, high-dose group), IL-
1ra levels (1.75 h, both groups), and saliva cortisol levels (high-dose
group at 4 and 24 h). Psychological variables showed non-normal
distributions for calmness (3 h and 6 h) and anxiety (3 h). In
contrast, all memory data were normally distributed. However, re-
calculation with log-transformed data to restore normal distribu-
tion confirmed the reported results.
Pearson correlation analyses were performed to analyze possible
associations between the neuropsychological outcome measures
and the immunological, physiological, and neuroendocrine
parameters. Changes in neuropsychological and mood variables
which were significantly affected by the endotoxin treatment were
correlated with changes in cytokines, neuroendocrine, and vital
parameters. The alpha level was adjusted according to the
respective number of comparisons (Bonferroni correction).
Results
Body temperature and heart rate
Both, low-dose and high-dose LPS treatment significantly increased
body temperature (Fig. 2A; low-dose: F=13.18, p,0.001; high-dose:
F=14.11, p,0.001) and heart rate (Fig. 2B; low-dose: F=10.49,
p,0.001, high-dose: F=9.12, p,0.001) without significant differ-
ences between LPS doses.
Cytokine levels
Endotoxin administration induced significant increases in
plasma concentrations of the pro-inflammatory cytokines IL-6
(low-dose: F=31.11, p,0.001, high-dose: F=17.74, p,0.001) and
TNF-a (low-dose: F=12.05, p,0.001, high-dose: F=21.26,
p,0.001) with most pronounced increases 1.75 h after LPS
injection (Fig. 3). Plasma TNF-a levels were significantly higher in
the high-dose compared to the low-dose group (F=5.02, p,0.001;
Fig. 3B), whereas IL-6 levels did not significantly differ between
doses (Fig. 3A). The anti-inflammatory cytokine IL-10 was
significantly increased in both endotoxin groups (low-dose:
F=25.47, p,0.001; high-dose: F=12.80, p,0.001) with signifi-
cantly more pronounced elevations in the high-dose group 3 h post
injection (F=5.02, p,0.001; Fig. 3C). The most pronounced
differences in cytokine levels between the two groups were
observed for IL-1 receptor antagonist (IL-1ra) (F=15.59,
p,0.001, low-dose vs. high-dose; F=33.45, p,0.001, high-dose vs.
control;F=21.01, p,.001, low-dose vs. control; Fig. 3D).
Neuroendocrine measures
Activation of the innate immune response by endotoxin
increases the activity of HPA axis and sympathetic nervous
Endotoxin and Human Neurobehavioral Functions
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tions as well as plasma norepinephrine levels. The neuroendocrine
response to LPS injection was reflected by marked increases in the
levels of total cortisol in plasma (low-dose: F=19.44, p,0.001; high-
dose: F=29.99, p,0.001; Fig. 4A) and free cortisol in the saliva
(low-dose: F=24.80, p,0.001; high-dose: F=20.40, p,0.001;
Fig. 4B) as well as plasma norepinephrine (low-dose: F=8.12,
p,0.001; high-dose: F=5.17, p,0.001; Fig. 4C). The rise of free
cortisol in saliva was significantly higher in the high-dose group than
in the low-dose group (F=2.27, p,0.05).
Mood & Anxiety
The effects of endotoxin treatment on mood and anxiety were
analyzed with two standardized questionnaires (MDBF, STAI) at
baseline as well as 3 h and 6 h after LPS injection (Fig. 5). Self-
reported positive mood (low-dose: F=6.21, p=0.01; high-dose:
F=25.97, p,0.001), calmness (low-dose: F=6.42, p,0.01; high-
dose: F=5.52, p,0.01), and alertness (low-dose: F=5.07, p,0.01;
high-dose: F=7.09, p,0.01), were significantly decreased 3 h after
endotoxin injection in both groups. The decrease in positive mood
was significantly more pronounced (26.00 vs. 22.06 at 3 h) in the
high- compared to the low-dose group (F=7.22, p=0.01). State
anxiety significantly increased after endotoxin administration in
both groups (low-dose: F=4.13, p,0.05; high-dose: F=6.47,
p,0.01).
Memory
Working memory was assessed 2 h after LPS injection with the
n-back task. Whereas the accuracy, represented by the number of
correct responses minus the number of ‘false alarms’ (i.e. a
response to an inadequate stimulus), remained unaffected by
endotoxin in both groups (Fig. 6A; F=0.20, p.0.05; low-dose group:
15.965.4 vs. 15.265.0,), there was a significant group6treatment
interaction for the mean reaction time (Fig. 6B; F=4.72, p,0.05),
which was significantly reduced by 27.6 ms after endotoxin
administration exclusively in the high-dose group (504.9671.5 ms)
compared to the placebo condition (532.5659.3 ms; t=3.21,
p,0.01; low dose group: 530.7658.2 vs. 532.6660.3 ms).
Long term memory performance for neutral and affective
contents was analyzed with standardized stimuli of the Interna-
tional Affective Picture System (IAPS) (see methods section,
examples given in Fig. S1). In general, subjects recognized
emotional stimuli better compared to stimuli with neutral content
indicated by a pronounced emotionality effect (F=26.26,
p,0.001, emotionality6treatment6group ANOVA) (Fig. 7). In
addition, we observed a significant treatment effect (F=7.36,
p,0.05) due to a decreased memory performance for emotional
(6.462.4 vs. 7.862.4) but not for neutral content (5.362.4 vs.
5.662.5) after endotoxin administration in the low-dose group
(t=2.88, p,0.05, Bonferroni corrected t-test). In contrast, a higher
dose of LPS did not significantly affect memory performance
neither for emotional (8.561.8 vs. 8.561.3) nor for neutral stimuli
(5.962.0 vs. 6.861.7; F=1.29, p.0.05), although there was a
trend towards decreased memory performance for neutral stimuli
after high-dose LPS treatment (t=2.09, p=0.10). Moreover,
ANOVA did not reveal significant treatment6group, emotiona-
lity6group, or treatment6emotionality effects, however showed a
significant treatment6emotionality6group interaction effect
(F=6.14, p,0.05) indicating a specific effect depending on the
quality of memory content and the employed dose of LPS.
Correlation analyses
In the high-dose group correlation analyses corrected for 8
comparisons revealed a negative association between changes in
IL-6 levels and positive mood (r=2.654, p,0.01), calmness
(r=2.654, p,0.01) as well as a positive correlation between IL-6
and state anxiety (r=.762, p,0.005). A correlation between IL-6
and mood in the low-dose group, however, failed to reach the
adjusted alpha level. In the low-dose group mood changes were
negatively correlated with the changes in plasma cortisol
(r=2.739, p,0.005) and saliva cortisol (r=2.652, p,0.01),
which was also seen in the high-dose group but failed to reach
statistical significance after alpha correction. Furthermore, chang-
es in plasma cortisol were associated with changes in state anxiety
within the low-dose group (r=.715, p,0.005).
Discussion
We employed a human endotoxemia model in healthy subjects
and analyzed the effects on circulating cytokines, neuroendocrine
parameters as well as mood and memory performance by either
administering lower (0.4 ng/kg) or higher (0.8 ng/kg) doses of
LPS. We observed significant, mainly dose-dependent, increases in
body temperature, heart rate, levels of pro- (IL-6, TNF-a) and
anti-inflammatory (IL-10, IL-1ra) cytokines, cortisol, and norepi-
nephrine. Significant, dose-related increases in negative mood and
Figure 2. Body temperature and heart rate. Absolute changes in body temperature and heart rate following the administration of 0.4 (solid
lines, n=18) or 0.8 ng/kg E. coli endotoxin (dashed lines, n=16). Data are presented as means 6 SEM. Significant differences between experimental
condition and respective saline control: *p,0.05, **p,0.01, ***p,0.001 (Bonferroni post hoc test).
doi:10.1371/journal.pone.0028330.g002
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sensed and processed by the CNS. LPS administration did not
affect accuracy in working memory, however induced a significant
improvement in reaction time in the high-dose LPS condition. In
contrast, long term-memory for emotional but not for neutral
stimuli was significantly impaired by the administration of low-dose
LPS, whereas in the high-dose LPS condition memory remained
unaffected.
The alterations in cytokines and cortisol levels observed in this
study resemble those reported in other studies employing
comparable amounts (0.4 ng/kg) of intravenously administered
LPS [36]. In addition, higher LPS concentration (0.8 ng/kg)
further increased TNF-a, IL-10 and IL-1ra plasma concentrations,
but not plasma levels of IL-6, cortisol, or norepinephrine. We also
observed a pronounced and dose-dependent impact of LPS on
self-reported mood with increased anxiety levels and impaired
calmness and alertness. Studies in experimental animals together
with clinical observations in humans suggest a cytokine-mediated
modulation of memory functions as a consequence of acute
peripheral inflammatory processes [3,37]. However, data in
humans so far reported inconsistent results of experimental
endotoxemia with a significant improvement [24] or no effect on
working memory [25,27]. These conflicting results might be either
due to the different experimentally induced grades of inflamma-
tion or the neuropsychological tools (Digit Span Forward,
Backward Test by Wechsler) employed in these studies to assess
working memory performance. These measures might not be
sensitive enough to detect small changes induced by experimental
manipulations in young, healthy subjects [38,39,40]. Thus, in the
current study we employed a computerized n-back paradigm (2-
back version), a well-evaluated sensitive tool to analyze working
memory functions [34,41,42]. We did not find any effect on
accuracy in the n-back test, reflected by the number of correct
responses minus the number of false reactions, neither in the low-
nor high-dose LPS condition. However, administration of 0.8 ng/kg
LPS significantly improved the reaction time, possibly indicating a
positive effect of the peripheral inflammation on alertness and
response speed rather than on memory performance. This data
might also explain the inconsistent results of former studies using
the Digit Span Tests by Wechsler, which does not allow analyzing
these two parameters separately [43]. Cytokine-cholinergic
interactions on the basis of a negative association between changes
in working memory performance and alterations in acetylcholin-
esterase (AChE-R) cleavage after LPS stimulation in humans have
been hypothesized as a possible mechanism for working memory
improvement [24]. Studies in rodents and monkeys have
established that acute stress rapidly impairs dorsolateral prefrontal
cortex (DLPFC) functioning via noradrenergic and dopaminergic
Figure 3. Cytokine response to LPS administration. Absolute changes in plasma concentrations of pro- (IL-6, TNF-a) and anti-inflammatory (IL-
10, IL-1ra) cytokines after administration of 0.4 (solid lines, n=18) or 0.8 ng/kg E. coli endotoxin (dashed lines, n=16). Data are presented as means 6
SEM. Significant differences between experimental condition and respective saline control: *p,0.05, **p,0.01, ***p,0.001; significant differences
between changes in high- and low-dose condition: ##p,0.01, ###p,0.001 (Bonferroni post hoc test).
doi:10.1371/journal.pone.0028330.g003
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lived [45]. In humans experimental or pharmacological stress
studies have reported inconsistent effects with impairments as well
as enhancements being reported [42,46,47]. Of interest for the
current experiments is a recent functional magnetic resonance
(fMRI) study reporting that several hours after cortisol intake
DLPFC activity during an n-back task was enhanced with a similar
trend being observed at the behavioral level. These authors suggest
that slow genomic effects of cortisol enhance PFC functioning
[48]. In line with this conclusion are recent findings in rodents
showing that acute stress enhanced working memory via an
enhancement of glutamatergic neurotransmission [49].
Interestingly, the profound decrease in self-reported alertness
clearly contrasts the improvement in reaction time measured with
the n-back test. Although the reasons for this discrepancy remain
unclear, it underlines the basic independency of these two
processes and might fortify the view on sickness behavior as an
adaptive response rather than a simple impairment by the
inflammatory challenge [4].
In parallel to working memory functions long term memory
performance was analyzed employing a picture-recognition test
consisting of neutral as well as emotional stimuli. Subjects were
exposed to the stimuli 3 h after LPS injection (acquisition) and
were asked to recall the stimuli 24 h later (Fig. 1). Under placebo
conditions, we observed improved memory performance for
emotionally arousing compared to neutral stimuli, confirming
earlier observations [50]. This effect reflects the modulatory role of
the amygdala on hippocampus based declarative and episodic
memory [51].
Administration of low-dose LPS 3 h before acquisition impaired
memory performance for emotional but not for neutral stimuli.
Surprisingly, this effect was not observed after administration of
the higher LPS dose, which did not significantly affect long term
memory performance neither for neutral nor for emotional
stimuli.
Animal data suggest detrimental effects of acute systemic
inflammation on long term memory [3,19,21,22,23]. However,
experimental data in humans are controversial, either reporting
impaired [24,28] or unaffected declarative memory performance
[25,26,27] after LPS administration. Since data on dose
dependent effects of LPS-induced inflammation on neural
responses are completely lacking, one can only hypothesize about
the underlying neurobiological mechanisms responsible for these
differential effects.
Two classes of soluble factors are most often discussed to
modulate cognitive functions during an inflammatory reaction:
cytokines and stress hormones. Under physiological conditions
cytokines have a beneficial role on learning and memory, e.g. by
promoting long term potentiation (LTP), neural plasticity and
neural excitability [3,52,53]. Administered in higher doses or
during acute inflammation cytokines demonstrated detrimental
effects on learning and memory [3,54,55]. A possible explanation
for this phenomenon was given by Yirmiya and Goshen, who
proposed a model of adaptive down-regulation of neural
excitability to prevent potentially dangerous hyper-excitability
and proneness to errors by the ‘‘price’’ of impairments of learning
Figure 4. Neuroendocrine responses to LPS administration.
Absolute changes in plasma concentrations of cortisol and norepi-
nephrine and salivary cortisol levels after administration of 0.4 (solid
lines, n=18) or 0.8 ng/kg E. coli endotoxin (dashed lines, n=16). Data
are presented as means 6 SEM. Significant differences between
experimental condition and respective saline control: *p,0.05,
**p,0.01, ***p,0.001 (Bonferroni post hoc test).
doi:10.1371/journal.pone.0028330.g004
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following low-dose LPS administration might reflect this down-
regulation of neural excitability. The abrogation of this impair-
ment in the high-dose LPS group might either reflect a balanced
state between cytokine induced increased neural excitability and
the counter-acting regulatory mechanisms, or might be due to
increased stress exposure: Behavioral and pharmacological studies
in humans showed enhanced long-term memory consolidation for
emotional stimuli after stress or glucocorticoid (GC) treatment
directly before or after encoding, while impairing the consolidation
of neutral material [56,57,58]. Thus, the absence of a memory
impairment of emotional stimuli in the high-dose LPS group
together with a trend towards impaired memory performance for
neutral stimuli might be due to actions of the higher and more
sustained cortisol response observed after high-dose LPS adminis-
tration. In addition, greater effects on mood and anxiety than after
low-dose stimulation, together with reduced reaction time in the
working memory test also might indicate an elevated stress
reaction and an ‘‘alarmed state’’ of the organism probably going
along with increased attention.
However, the exact nature of possible compensatory mecha-
nisms and in particular the question whether the compensatory
effect on memory performance is paralleled by or due to increased
attention need to be addressed in future studies.
The observation that in this study only memory performance
for emotional stimuli was impaired by LPS administration together
with the pronounced effects on mood and anxiety indicate that
predominantly limbic structures like the amygdala are affected by
an acute peripheral inflammatory response. This hypothesis is
supported by recent work in rodents, which demonstrated
enhanced neural activity in the amygdala after peripheral LPS-
administration [59,60]. However, a recent fMRI study also
employing endotoxin application in humans did not report
changes of neural activations in the amygdala [61]. In this study,
we focused on LPS-effects on the acquisition phase of the memory
process with differential and dose-dependent effects on short and
long term memory. However, the distinct effects of peripheral
transient inflammatory responses on memory processes such as
consolidation and retrieval are still unknown and might, as a target
for future studies, help to further complete the puzzle of immune-
to-brain communication.
Correlation analyses revealed strong associations between the
increases in anxiety and negative mood and circulating IL-6 levels
in the high-dose and concentrations of cortisol in the low-dose LPS
Figure 5. LPS effects on mood and anxiety. Absolute changes in mood, calmness, and alertness (MDBF) and in state anxiety (STAI) after
administration of 0.4 (solid lines, n=18) or 0.8 ng/kg E. coli endotoxin (dashed lines, n=16). Data are presented as means 6 SEM. Significant
differences between experimental condition and respective saline control: *p,0.05, **p,0.01, ***p,0.001; significant differences between changes
in high- and low-dose condition: ##p,0.01, ###p,0.001 (Bonferroni post hoc test).
doi:10.1371/journal.pone.0028330.g005
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mood have been reported previously [28,62] and IL-6 frequently
has been discussed as a potential modulator of mood during
sickness behavior and even depression and other neuropsycholog-
ical diseases [2,3,9]. HPA system activation with increased levels of
cortisol and corticotropin releasing hormone have also been
suggested to play a role in depressive symptoms and in mediating
inflammatory effects on mood and anxiety [6,28,37,63]. Our
results confirm earlier observations which suggested both circu-
lating cytokines as well as cortisol to be involved in mediating the
effects on emotions [28]. The data in the current study show an
association between cortisol and mood parameters at a lower
grade of inflammation in contrast to a more pronounced
inflammatory effect where mood parameters are predominantly
associated to IL-6 levels.
In summary, LPS administration in healthy male subjects
induced a transient, dose-dependent inflammatory response
characterized by increases in body temperature and heart-rate,
plasma concentrations of pro- and anti-inflammatory cytokines,
cortisol, and norepinephrine. In parallel, we observed dose-
dependent increases in negative mood and anxiety. There was a
significant improvement in reaction times during a working
memory performance task after high-dose LPS stimulation, whereas
accuracy in the same test remained unaffected under both
conditions. The innate immune response resulted in impaired
memory performance for emotionally arousing material within the
low-dose LPS condition. This study demonstrates that sub-septic
systemic inflammation in humans along with the release of pro-
and anti-inflammatory cytokines does dose-dependently affect
neurobehavioral functions in humans reflecting an adaptive
response as a consequence of a refined immune-to-brain
communication.
Supporting Information
Figure S1 Stimuli examples for long-term memory task.
Emotional stimuli rated with high arousal and low valence score
(A) and neutral stimuli rated with low arousal and medium valence
score (B).
(TIF)
Figure S2 Illustration of the n-back task paradigm. After
a training phase a consecutive sequence of 155 letters was
presented on a computer screen with a presentation time of
1 second for each letter and a 30 seconds break after every 31
letters. The participants were instructed to press a button
whenever the letter currently presented was identical to the
penultimate. Stimuli were presented 25 times throughout the
whole sequence in a randomized manner. Reaction time and the
numbers of correct reactions (cr) and false alarms (fa) were assessed
and accuracy (=cr - fa) was calculated.
(TIF)
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